Toward an early diagnostic tool for Alzheimer's disease

August 29, 2013, INRS

Despite all the research done on Alzheimer's, there is still no early diagnostic tool for the disease. By looking at the brain wave components of individuals with the disease, Professor Tiago H. Falk of INRS's Centre Énergie Matériaux Télécommunications has identified a promising avenue of research that may not only help diagnose the disease, but also assess its severity. This non-invasive, objective method is the subject of an article in the journal PLOS ONE.

Patients with Alzheimer's disease currently undergo neuropsychological testing to detect signs of the disease. The test results are difficult to interpret and are insufficient for making a . But as scientists have already discovered, activity in certain areas of the is affected even in the early stages of the disease. Professor Falk, who specialises in biological , examined this phenomenon and compared the electroencephalograms (EEGs) of healthy individuals (27), individuals with mild Alzheimer's (27), and individuals with moderate cases of the disease (22). He found statistically significant differences across the three groups.

In collaboration with and Francisco J. Fraga, an INRS visiting professor specializing in biological signals, Professor Falk used an algorithm that dissects brain waves of varying frequencies. "What makes this algorithm innovative is that it characterizes the changes in temporal dynamics of the patients' ," explains Professor Falk. "The findings show that healthy individuals have different patterns than those with mild Alzheimer's disease. We also found a difference between patients with mild levels of the disease and those with moderate Alzheimer's."

To validate the model in order to eventually develop an early diagnostic tool for Alzheimer's disease, Professor Falk's team is sharing their algorithm on the NeuroAccelerator.org online data analysis portal. It is the first open source algorithm posted on the portal and may be used by researchers around the world to produce additional research findings.

Alzheimer's disease accounts for 60% to 80% of all dementia cases in North America and is skyrocketing. This step toward the development of an early that is non-invasive, objective, and relatively inexpensive is therefore welcome news for the research community.

Explore further: What goes wrong in a brain affected by Alzheimer's disease?

More information: "Characterizing Alzheimer's Disease Severity via Resting-Awake EEG Amplitude Modulation Analysis," www.plosone.org/article/info%3 … journal.pone.0072240

Related Stories

What goes wrong in a brain affected by Alzheimer's disease?

August 22, 2013
The ability of different regions of the brain to communicate gradually breaks down with aging and in Alzheimer's disease, but there are key differences between these two processes. Some of these differences are reported in ...

Early detection and treatment of Alzheimer's disease prevents psychological and behavioral symptoms

July 18, 2013
Persons with Alzheimer's disease are able to manage their everyday activities longer and they suffer from less psychological and behavioural symptoms if the diagnosis is made and treatment begun at a very early phase of the ...

Scientists spot early signs of Alzheimer's disease

July 9, 2013
Early signs of Alzheimer's disease can be detected years before diagnosis, according to researchers at Birmingham City University.

Brain network decay detected in early Alzheimer's

August 19, 2013
In patients with early Alzheimer's disease, disruptions in brain networks emerge about the same time as chemical markers of the disease appear in the spinal fluid, researchers at Washington University School of Medicine in ...

Forget about plaque when diagnosing Alzheimer's Disease

April 3, 2013
(Medical Xpress)—An Australian study has shown that plaque, long considered to be the hallmark of Alzheimer's disease, is one of the last events to occur in the Alzheimer's brain. This finding will impact the current debate ...

Recommended for you

Energy storehouses in the brain may be source of Alzheimer's, targets of new therapy

January 23, 2018
Alzheimer's disease, a severely debilitating and ultimately fatal brain disorder, affects millions worldwide. To date, clinical efforts to find a cure or adequate treatment have met with dispiriting failure.

Rocky start for Alzheimer's drug research in 2018

January 19, 2018
The year 2018, barely underway, has already dealt a series of disheartening blows to the quest for an Alzheimer's cure.

Alzheimer's disease: Neuronal loss very limited

January 17, 2018
Frequently encountered in the elderly, Alzheimer's is considered a neurodegenerative disease, which means that it is accompanied by a significant, progressive loss of neurons and their nerve endings, or synapses. A joint ...

Anxiety: An early indicator of Alzheimer's disease?

January 12, 2018
A new study suggests an association between elevated amyloid beta levels and the worsening of anxiety symptoms. The findings support the hypothesis that neuropsychiatric symptoms could represent the early manifestation of ...

One of the most promising drugs for Alzheimer's disease fails in clinical trials

January 11, 2018
To the roughly 400 clinical trials that have tested some experimental treatment for Alzheimer's disease and come up short, we can now add three more.

Different disease types associated with distinct amyloid-beta prion strains found in Alzheimer's patients

January 9, 2018
An international team of researchers has found different disease type associations with distinct amyloid-beta prion strains in the brains of dead Alzheimer's patients. In their paper published in Proceedings of the National ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.